Found: 83
Select item for more details and to access through your institution.
Myeloid-derived suppressor cells in multiple myeloma: pre-clinical research and translational opportunities.
- Published in:
- Frontiers in Oncology, 2014, v. 4, p. 1, doi. 10.3389/fonc.2014.00348
- By:
- Publication type:
- Article
Chromene Derivatives as Selective TERRA G-Quadruplex RNA Binders with Antiproliferative Properties.
- Published in:
- Pharmaceuticals (14248247), 2022, v. 15, n. 5, p. 548, doi. 10.3390/ph15050548
- By:
- Publication type:
- Article
Non-coding RNAs in cancer: platforms and strategies for investigating the genomic "dark matter".
- Published in:
- Journal of Experimental & Clinical Cancer Research (17569966), 2020, v. 39, n. 1, p. 1, doi. 10.1186/s13046-020-01622-x
- By:
- Publication type:
- Article
Trabectedin triggers direct and NK-mediated cytotoxicity in multiple myeloma.
- Published in:
- Journal of Hematology & Oncology, 2019, v. 12, n. 1, p. N.PAG, doi. 10.1186/s13045-019-0714-9
- By:
- Publication type:
- Article
MALAT1: a druggable long non-coding RNA for targeted anti-cancer approaches.
- Published in:
- 2018
- By:
- Publication type:
- Abstract
The New Microtubule-Targeting Agent SIX2G Induces Immunogenic Cell Death in Multiple Myeloma.
- Published in:
- International Journal of Molecular Sciences, 2022, v. 23, n. 18, p. N.PAG, doi. 10.3390/ijms231810222
- By:
- Publication type:
- Article
Oleil Hydroxytyrosol (HTOL) Exerts Anti-Myeloma Activity by Antagonizing Key Survival Pathways in Malignant Plasma Cells.
- Published in:
- International Journal of Molecular Sciences, 2021, v. 22, n. 21, p. 11639, doi. 10.3390/ijms222111639
- By:
- Publication type:
- Article
MicroRNAs: Novel Crossroads between Myeloma Cells and the Bone Marrow Microenvironment.
- Published in:
- BioMed Research International, 2016, v. 2016, p. 1, doi. 10.1155/2016/6504593
- By:
- Publication type:
- Article
OSAnalyzer: A Bioinformatics Tool for the Analysis of Gene Polymorphisms Enriched with Clinical Outcomes.
- Published in:
- Microarrays (2076-3905), 2016, v. 5, n. 4, p. 24, doi. 10.3390/microarrays5040024
- By:
- Publication type:
- Article
Pembrolizumab plus lenvatinib in advanced endometrial cancer: case report and systematic review of lung toxicity.
- Published in:
- Frontiers in Oncology, 2023, p. 1, doi. 10.3389/fonc.2023.1145986
- By:
- Publication type:
- Article
Autoimmune colitis and neutropenia in adjuvant anti-PD-1 therapy for malignant melanoma: efficacy of Vedolizumab, a case report.
- Published in:
- Therapeutic Advances in Chronic Disease, 2022, p. 1, doi. 10.1177/20406223211063024
- By:
- Publication type:
- Article
Autoimmune colitis and neutropenia in adjuvant anti-PD-1 therapy for malignant melanoma: efficacy of Vedolizumab, a case report.
- Published in:
- Therapeutic Advances in Chronic Disease, 2022, p. 1, doi. 10.1177/20406223211063024
- By:
- Publication type:
- Article
miR-221 stimulates breast cancer cells and cancer-associated fibroblasts (CAFs) through selective interference with the A20/c-Rel/CTGF signaling.
- Published in:
- Journal of Experimental & Clinical Cancer Research (17569966), 2018, v. 37, n. 1, p. N.PAG, doi. 10.1186/s13046-018-0767-6
- By:
- Publication type:
- Article
The role of brain radiotherapy for EGFR- and ALK-positive non-small-cell lung cancer with brain metastases: a review.
- Published in:
- La Radiologia Medica, 2023, v. 128, n. 3, p. 316, doi. 10.1007/s11547-023-01602-z
- By:
- Publication type:
- Article
The Cyclophilin A-CD147 complex promotes the proliferation and homing of multiple myeloma cells.
- Published in:
- Nature Medicine, 2015, v. 21, n. 6, p. 572, doi. 10.1038/nm.3867
- By:
- Publication type:
- Article
UMG1/CD3ε‐bispecific T‐cell engager redirects T‐cell cytotoxicity against diffuse large B‐cell lymphoma.
- Published in:
- British Journal of Haematology, 2024, v. 204, n. 2, p. 555, doi. 10.1111/bjh.19183
- By:
- Publication type:
- Article
Exploiting DNA Ligase III addiction of multiple myeloma by flavonoid Rhamnetin.
- Published in:
- 2022
- By:
- Publication type:
- journal article
Delivery of miR-34a by chitosan/PLGA nanoplexes for the anticancer treatment of multiple myeloma.
- Published in:
- Scientific Reports, 2015, v. 5, n. 1, p. 17579, doi. 10.1038/srep17579
- By:
- Publication type:
- Article
<i>In Vivo</i> Activity of MiR-34a Mimics Delivered by Stable Nucleic Acid Lipid Particles (SNALPs) against Multiple Myeloma.
- Published in:
- PLoS ONE, 2014, v. 9, n. 2, p. 1, doi. 10.1371/journal.pone.0090005
- By:
- Publication type:
- Article
<i>In Vitro</i> and <i>In Vivo</i> Activity of a Novel Locked Nucleic Acid (LNA)-Inhibitor-miR-221 against Multiple Myeloma Cells.
- Published in:
- PLoS ONE, 2014, v. 9, n. 2, p. 1, doi. 10.1371/journal.pone.0089659
- By:
- Publication type:
- Article
Automatic summarisation and annotation of microarray data.
- Published in:
- Soft Computing - A Fusion of Foundations, Methodologies & Applications, 2011, v. 15, n. 8, p. 1505, doi. 10.1007/s00500-010-0600-4
- By:
- Publication type:
- Article
Phase I trial of thymidylate synthase poly-epitope peptide (TSPP) vaccine in advanced cancer patients.
- Published in:
- Cancer Immunology, Immunotherapy, 2015, v. 64, n. 9, p. 1159, doi. 10.1007/s00262-015-1711-7
- By:
- Publication type:
- Article
New pharmacokinetic and pharmacodynamic tools for interferon-alpha (IFN-a) treatment of human cancer.
- Published in:
- Cancer Immunology, Immunotherapy, 2005, v. 54, n. 1, p. 1, doi. 10.1007/s00262-004-0549-1
- By:
- Publication type:
- Article
The farnesyl transferase inhibitor R115777 (Zarnestra<sup>®</sup>) synergistically enhances growth inhibition and apoptosis induced on epidermoid cancer cells by Zoledronic acid (Zometa<sup>®</sup>) and Pamidronate.
- Published in:
- Oncogene, 2004, v. 23, n. 41, p. 6900, doi. 10.1038/sj.onc.1207814
- By:
- Publication type:
- Article
Gut Microbiota Are a Novel Source of Biomarkers for Immunotherapy in Non-Small-Cell Lung Cancer (NSCLC).
- Published in:
- Cancers, 2024, v. 16, n. 10, p. 1806, doi. 10.3390/cancers16101806
- By:
- Publication type:
- Article
Lynch Syndrome Biopathology and Treatment: The Potential Role of microRNAs in Clinical Practice.
- Published in:
- Cancers, 2023, v. 15, n. 15, p. 3930, doi. 10.3390/cancers15153930
- By:
- Publication type:
- Article
The First-In-Class Anti-AXL×CD3ε Pronectin™-Based Bispecific T-Cell Engager Is Active in Preclinical Models of Human Soft Tissue and Bone Sarcomas.
- Published in:
- Cancers, 2023, v. 15, n. 6, p. 1647, doi. 10.3390/cancers15061647
- By:
- Publication type:
- Article
miR-22 Modulates Lenalidomide Activity by Counteracting MYC Addiction in Multiple Myeloma.
- Published in:
- Cancers, 2021, v. 13, n. 17, p. 4365, doi. 10.3390/cancers13174365
- By:
- Publication type:
- Article
miRNAs and lncRNAs as Novel Therapeutic Targets to Improve Cancer Immunotherapy.
- Published in:
- Cancers, 2021, v. 13, n. 7, p. 1587, doi. 10.3390/cancers13071587
- By:
- Publication type:
- Article
Alternative Non-Homologous End-Joining: Error-Prone DNA Repair as Cancer's Achilles' Heel.
- Published in:
- Cancers, 2021, v. 13, n. 6, p. 1392, doi. 10.3390/cancers13061392
- By:
- Publication type:
- Article
Expression Pattern and Biological Significance of the lncRNA ST3GAL6-AS1 in Multiple Myeloma.
- Published in:
- Cancers, 2020, v. 12, n. 4, p. 782, doi. 10.3390/cancers12040782
- By:
- Publication type:
- Article
The Non-Coding RNA Landscape of Plasma Cell Dyscrasias.
- Published in:
- Cancers, 2020, v. 12, n. 2, p. 320, doi. 10.3390/cancers12020320
- By:
- Publication type:
- Article
Allometric Scaling Approaches for Predicting Human Pharmacokinetic of a Locked Nucleic Acid Oligonucleotide Targeting Cancer-Associated miR-221.
- Published in:
- Cancers, 2020, v. 12, n. 1, p. 27, doi. 10.3390/cancers12010027
- By:
- Publication type:
- Article
Anti-tumor Activity and Epigenetic Impact of the Polyphenol Oleacein in Multiple Myeloma.
- Published in:
- Cancers, 2019, v. 11, n. 7, p. 990, doi. 10.3390/cancers11070990
- By:
- Publication type:
- Article
Replacement of miR-155 Elicits Tumor Suppressive Activity and Antagonizes Bortezomib Resistance in Multiple Myeloma.
- Published in:
- Cancers, 2019, v. 11, n. 2, p. 236, doi. 10.3390/cancers11020236
- By:
- Publication type:
- Article
Nanoparticle Albumin Bound Paclitaxel in the Treatment of Human Cancer: Nanodelivery Reaches Prime-Time?
- Published in:
- Journal of Drug Delivery, 2013, p. 1, doi. 10.1155/2013/905091
- By:
- Publication type:
- Article
Physicochemical features and transfection properties of chitosan/poloxamer 188/poly(D,L-lactide-co-glycolide) nanoplexes.
- Published in:
- International Journal of Nanomedicine, 2014, v. 9, p. 2359, doi. 10.2147/IJN.S58362
- By:
- Publication type:
- Article
DMET-Analyzer: automatic analysis of Affymetrix DMET Data.
- Published in:
- BMC Bioinformatics, 2012, v. 13, n. 1, p. 258, doi. 10.1186/1471-2105-13-258
- By:
- Publication type:
- Article
TERRA G‐quadruplex stabilization behind the anti‐multiple myeloma activity: Novel insights about resveratrol pleiotropic effects.
- Published in:
- Archiv der Pharmazie, 2024, v. 357, n. 10, p. 1, doi. 10.1002/ardp.202400269
- By:
- Publication type:
- Article
Hit identification of novel small molecules interfering with MALAT1 triplex by a structure‐based virtual screening.
- Published in:
- Archiv der Pharmazie, 2023, v. 356, n. 8, p. 1, doi. 10.1002/ardp.202300134
- By:
- Publication type:
- Article
Bergamot Polyphenols Improve Dyslipidemia and Pathophysiological Features in a Mouse Model of Non-Alcoholic Fatty Liver Disease.
- Published in:
- Scientific Reports, 2020, v. 10, n. 1, p. 1, doi. 10.1038/s41598-020-59485-3
- By:
- Publication type:
- Article
Small nucleolar RNAs as new biomarkers in chronic lymphocytic leukemia.
- Published in:
- BMC Medical Genomics, 2013, v. 6, n. 1, p. 1, doi. 10.1186/1755-8794-6-27
- By:
- Publication type:
- Article
Immune-related [<sup>18</sup>F]FDG PET findings in patients undergoing checkpoint inhibitors treatment: correlation with clinical adverse events and prognostic implications.
- Published in:
- Cancer Imaging, 2024, v. 24, n. 1, p. 1, doi. 10.1186/s40644-024-00774-9
- By:
- Publication type:
- Article
The farnesyltransferase inhibitor R115777 (ZARNESTRA®) enhances the pro-apoptotic activity of interferon-α through the inhibition of multiple survival pathways.
- Published in:
- International Journal of Cancer, 2007, v. 121, n. 10, p. 2317, doi. 10.1002/ijc.22964
- By:
- Publication type:
- Article
Epigenetic inactivation of RUNX3 in microsatellite unstable sporadic colon cancers.
- Published in:
- International Journal of Cancer, 2004, v. 112, n. 5, p. 754, doi. 10.1002/ijc.20472
- By:
- Publication type:
- Article
OAB-009: Genome-wide CRISPR interference screen identifies RNA Regulator of Lipogenesis (RROL) as a leading LncRNA dependency in Multiple Myeloma.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2021, v. 21, p. S6, doi. 10.1016/S2152-2650(21)02083-8
- By:
- Publication type:
- Article
Discovery, Functional Characterization and Therapeutic Targeting of Lnc-17-92 Metabolic Signaling in Multiple Myeloma.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2019, v. 19, p. e107, doi. 10.1016/j.clml.2019.09.176
- By:
- Publication type:
- Article
FlowCT: A semi-automated workflow for deconvolution of immunophenotypic data and objective reporting on large datasets.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2019, v. 19, p. e94, doi. 10.1016/j.clml.2019.09.153
- By:
- Publication type:
- Article
Polymorphic Variants in NR1I3 and UGT2B7 Predict Taxane Neurotoxicity and Have Prognostic Relevance in Patients With Breast Cancer: A Case‐Control Study.
- Published in:
- Clinical Pharmacology & Therapeutics, 2019, v. 106, n. 2, p. 422, doi. 10.1002/cpt.1391
- By:
- Publication type:
- Article
Identification of polymorphic variants associated with erlotinib-related skin toxicity in advanced non-small cell lung cancer patients by DMET microarray analysis.
- Published in:
- 2016
- By:
- Publication type:
- journal article